Whole genome sequencing (WGS) of tumor-normal sample pairs is a powerful approach for comprehensively characterizing germline copy number variations and somatic copy number alterations in cancer research and clinical practice. Existing computational approaches for detecting copy number events cannot detect germline copy number variations and somatic copy number alterations simultaneously, and yield low accuracy for somatic copy number alterations.